Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
112 participants
INTERVENTIONAL
2016-10-10
2018-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Motor and cognitive impairment are currently also treated separately whereas real life performance very often requiring an integrated motor and cognitive function. So far, no studies in MS have investigated the effects of physical or cognitive exercises on DT performances, or investigated effects of integrated cognitive-motor dual task training (DTT). In elderly and other neurological conditions, superior effects of dual task training (DTT) on gait training have been suggested, but the evidence is not robust yet. All these studies suggest the feasibility of DTT on gait improvement and fall risk reduction, but further insights on factors identifying responders, and differential effect of cognitive distractors needs further elucidation.
This research consist of two parts that aim to investigate:
Part 1: Assessment
1. the magnitude of the dual task cost according to different types of cognitive distractors (information processing, memory, attention, etc.),
2. its reliability as experimental outcome measure and
3. its association with factors as severity of cognitive or motor dysfunction, quality of life and fatigue.
Part 2: Intervention
1. the effectiveness of cognitive-motor DT-based training programs compared to single modality training, on DT and ST performances (cognition and mobility)
2. whether dual task learning effects transfer to improvements in daily life and are sustained for 4 weeks without training
3. which patient profiles benefit most from the integrated cognitive-motor training
4. feasibility and usefulness of an adaptive, interactive ICT-guided DTT system.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Attention Retraining in MS
NCT01492023
Cognitive-motor Telerehabilitation in MS
NCT05355389
Computerized Cognition Testing and Cognitive Motor Interference in MS
NCT02318576
Neuropsychological Management of Multiple Sclerosis: Benefits of a Computerised Semi-autonomous At-home Cognitive Rehabilitation Programme
NCT03471338
Improving Cognition in People With Progressive Multiple Sclerosis Using Aerobic Exercise and Cognitive Rehabilitation
NCT03679468
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dual Task Training (DTT)
Dual Task Training
In total 12 Dual Task conditions will be performed in which 3 cognitive tasks are combined with 4 motor tasks:
Cognitive tasks:
* Titrated digit span backwards
* Auditory vigilance with alphabets
* Subtracting by 7
Motor tasks:
* Walking at self-selected speed
* Walking while carrying a cup of water
* Walking while stepping over obstacles
* Walking crisscross
Single Mobility Training (SMT)
Single Mobility Training
standard routine training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dual Task Training
In total 12 Dual Task conditions will be performed in which 3 cognitive tasks are combined with 4 motor tasks:
Cognitive tasks:
* Titrated digit span backwards
* Auditory vigilance with alphabets
* Subtracting by 7
Motor tasks:
* Walking at self-selected speed
* Walking while carrying a cup of water
* Walking while stepping over obstacles
* Walking crisscross
Single Mobility Training
standard routine training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* EDSS ≥2 and ≤ 6
* No relapse within the last 30 days
* No changes in disease modifying treatment and no corticoid-therapy within the last 50 days
* All types of MS
* Minimal cognitive functioning (MMSE≥26)
* Presence of dual task interference (dual task screening list ≥1)
Exclusion Criteria
* Other neurological diagnoses
* MS-like syndroms such as neruomyelitis optica
* Not able to understand and execute simple instructions
* Problems (even after adjustment with hearing aids or glasses) with hearing or vision interfering with the assessment or training.
* Ongoing dual task training or other interfering physical therapy or cognitive training/neuropsychological rehabilitation.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Revalidatie & MS Centrum Overpelt
OTHER
National MS Center Melsbroek
OTHER
AZ Klina
OTHER
Centre Hospitalier Universitaire de Liege
OTHER
Masku Neurological Rehabilitation Centre
UNKNOWN
Tel Aviv University
OTHER
Sheba Medical Center
OTHER_GOV
AISM Rehabilitation Service of Genoa
UNKNOWN
Hasselt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peter Feys
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Feys, prof. dr.
Role: PRINCIPAL_INVESTIGATOR
Hasselt University
Ilse Baert, drs.
Role: STUDY_CHAIR
Hasselt University
Renee Veldkamp, drs.
Role: STUDY_CHAIR
Hasselt University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Revalidatie & MS Centrum Overpelt
Overpelt, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MCS-IV-CMI&DTT-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.